Methods for treating mucopolysaccharidosis
US-2024374534-A1 · Nov 14, 2024 · US
US9616161B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9616161-B2 |
| Application number | US-201214128375-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 11, 2012 |
| Priority date | Jun 20, 2011 |
| Publication date | Apr 11, 2017 |
| Grant date | Apr 11, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention concerns a dialysis acid precursor composition for use during preparation of a dialysis acid concentrate solution and for mixing with water and a bicarbonate containing concentrate into a ready-for-use dialysis solution. Said dialysis acid precursor composition consists of powder components comprising sodium chloride, at least one dry acid and at least one calcium salt, and optionally potassium salt, magnesium salt, and glucose. According to the invention said at least one calcium salt and said optional glucose, are present as anhydrous components in said dialysis acid precursor composition.
Opening claim text (preview).
The invention claimed is: 1. A dialysis acid precursor composition for use during preparation of a dialysis acid concentrate solution and for mixing with water and a bicarbonate containing concentrate into a ready-for-use dialysis solution, the dialysis acid precursor composition consisting of: powder components comprising a sodium chloride powder, at least one dry acid powder and at least one calcium chloride powder, wherein the calcium chloride is present as an anhydrous component in the dialysis acid precursor composition, and the calcium chloride is in a quantity such that a concentration of 30-125 mM calcium ions is provided in the dialysis acid concentrate solution. 2. A dialysis precursor composition according to claim 1 , wherein said at least one dry acid is selected from the group comprising lactic acid, citric acid, gluconic acid, glucono-δ-lactone, N-acetyl cystein and α-lipoic acid. 3. A dialysis precursor composition according to claim 1 , wherein said dialysis precursor composition is configured to be mixed with a prescribed volume of water to provide a dialysis acid concentrate solution. 4. The dialysis precursor composition of claim 1 wherein the powder components further comprise at least one of a potassium salt, a magnesium salt and an anhydrous glucose.
Monosaccharides having only carbon, hydrogen and oxygen atoms · CPC title
Parenteral nutrition; Parenteral nutrition compositions as drug carriers · CPC title
Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars · CPC title
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00 · CPC title
Carbonates; Bicarbonates · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.